Our Practice


Specialty: Adult Neuropsychiatry
Sub-specialty: EEG Directed Neuropharmacology
Appointments: Asst. Clinical Professor of Psychiatry, UCSF

Education and Training

Professional Affiliations:

Association of American Physicians and Surgeons
EEG & Clinical Neuroscience Society

 Dr. Schiller, former Assistant Clinical Professor at UCSF,  held the position since finishing his research fellowship at that university in 1995. He came to San Francisco following completion of his residency at Yale University and medical school at the University of Chicago. He is the author of a number of scientific and general medical papers and divides his time between clinical practice and research into rEEG. In addition, he is President of the Association of American Physicians and Surgeons, a national physician association dedicated to maintaining a strong patient-physician relationship through the free practice of private medicine.

Dr. Schiller was increasingly frustrated by what he saw as the subjective nature of psychiatric treatment. Psychiatric diagnosis is based upon a classification scheme developed by the American Psychiatric Association. Although this was a step to make psychiatric diagnosis more objective, the fact remains that psychiatric diagnoses are determined by a committee which lists the symptoms and behaviors that they believe make up a disorder. Unlike other areas of medicine, there is no demonstrable, physical pathology available to validate these diagnoses. Most psychiatric symptoms are also shared among a number of different diagnoses so that diagnosis is often just a matter of opinion. Even when the diagnosis is clear according to the current diagnostic scheme, the process of medication treatment is still a very trial and error process.  

     Through a fortunate chance, Dr. Schiller met the founders of rEEG. He was immediately intrigued by the possibility of finally having an objective, physiologic basis for psychiatric treatment. Convinced that rEEG had the promise to fundamentally improve the nature of psychiatric treatment, he began to work with the founders on developing and pursuing further research into rEEG.